Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: Final report of a randomized controlled trial

Annals of Internal Medicine

Volumn 123, Issue 6, 1995, Pages 401-408

  Pak, Charles Y C ^a,b   Sakhaee, Khashayar ^b   Adams Huet, Beverley ^b   Piziak, Veronica ^c   Peterson, Roy D ^b   Poindexter, John R ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE CALCIUM; FLUORIDE SODIUM; PLACEBO;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL; SUSTAINED RELEASE PREPARATION; VERTEBRA FRACTURE;

EID: 0029090252     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-123-6-199509150-00001     Document Type: Article

References (22)

1. Farley JR, Wergedal JE, Baylink DJ. Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells. Science. 1983;222:330-2.
2. 3H] thymidine uptake in a human osteoblastic osteosarcoma cell line is dependent on transforming growth factor β. J Bone Miner Res. 1993; 8:19-25.
3. Faccini JM, Teotia SP. Histopathological assessment of endemic skeletal fluorosis. Calcif Tissue Res. 1974;16:45-57.
4. Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Eng J Med. 1990;322:802-9.
5. Pak CY, Sakhaee K, Zerwekh JE, Parcel C, Peterson R, Johnson K. Safe and effective treatment of osteoporosis with intermittent slow-release sodium fluoride: Augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab. 1989;68:150-9.
6. Pak CY, Sakhaee K, Piziak V, Peterson RD, Breslau NA, Boyd P, et al. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. Ann Intern Med. 1994;120:625-32.
7. Pak CY, Sakhaee K, Parcel C, Poindexter J, Adams B, Bahar A, et al. Fluoride bioavailability from slow-release sodium fluoride given with calcium citrate. J Bone Miner Res. 1990;5:857-62.
8. Taves DR. New approach to the treatment of bone disease with fluoride. Federation Proceedings. 1970;29:1185-7.
9. Sakhaee K, Pak CY. Fluoride bioavailability from immediate-release sodium fluoride with calcium carbonate compared with slow-release sodium fluoride with calcium citrate. Bone Miner. 1991;14:131-6.
10. Zerwekh JE, Antich PP, Sakhaee K, Prior J, Gonzales J, Gottschalk F, et al. Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporosis patients. Bone Miner. 1992;18:65-76.
11. Zerwekh JE, Antich PP, Sakhaee K, Gonzales J, Gottschalk F, Pak CY. Assessment by reflection ultrasound method of the effect of intermittent slow-release sodium fluoride-calcium citrate therapy on material strength of bone. J Bone Miner Res. 1991;6:239-44.
12. Antich PP, Pak CY, Gonzales J, Anderson J, Sakhaee K, Rubin C. Measurement of intrinsic bone strength in vivo by reflection ultrasound: correction of impaired quality with slow-release sodium fluoride and calcium citrate. J Bone Miner Res. 1993;8:301-11.
13. Pak CY, Sakhaee K, Antich PP, Zerwekh JE, Peterson RD, Piziak V, et al. 1993. Update on the treatment of osteoporosis with intermittent sodium fluoride and calcium citrate. In: Christiansen C, Riis B, eds. Fourth International Symposium on Osteoporosis. Hong Kong; 1993: 122-4.
14. Smith-Bindman R, Cummings SR, Steiger P, Genant HK. A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res. 1991;6:25-34.
15. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990;323:73-9.
16. Lee ET. Statistical Methods for Survival Data Analysis. 2nd ed. New York: J. Wiley; 1992.
17. Zerwekh JE, Hagler HK, Sakhaee K, Gottschalk F, Peterson RD, Pak CY. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis. Bone. 1994;15:691-9.
18. Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, et al. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med. 1993;95:557-67.
19. Antich PP, Wessels M, Mason RP, McColl R, Zerwekh J, Pak CY. Trabecular architecture studies by 3D MRI microscopy in bone biopsies. J Bone Min Res. 1994;9:S327.
20. Harvey JA, Zobitz MM, Pak CY. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res. 1988;3:253-8.
21. Pak, CY, Poindexter J, and Finlayson B. A model system for assessing physicochemical factors affecting calcium absorbability from the intestinal tract. J Bone Miner Res. 1989;4:119-27.
22. 3. In: Christiansen C, Riis B, eds. Fourth International Symposium on Osteoporosis. Hong Kong; 1993: 146-7.